XML 35 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated statements of income - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Consolidated statements of income [Abstract]      
Sales € 17,827 € 17,156 € 17,313
Cost of sales 10,633 9,988 9,493
Gross margin 7,194 7,168 7,820
Selling expenses 4,609 4,258 4,054
General and administrative expenses 671 599 630
Research and development expenses 2,103 1,806 1,822
Impairment of goodwill [1] 1,357 15 144
Other business income 127 186 122
Other business expenses 109 123 29
Income from operations (1,529) 553 1,264
Financial income 58 149 158
Financial expenses 258 188 202
Investments in associates, net of income taxes (2) (4) (9)
Income before taxes (1,731) 509 1,211
Income tax expenses (113) (103) 212
Income from continuing operations (1,618) [1] 612 [2] 999 [1]
Discontinued operations, net of income taxes 13 [2] 2,711 [1] 196 [1]
Net income [1] (1,605) 3,323 1,195
Net income attributable to shareholders of Koninklijke Philips N.V [2] (1,608) 3,319 1,187
Net income attributable to non-controlling interests € 3 [2] € 4 [2] € 8 [1]
Basic earnings per common share attributable to shareholders of Koninklijke Philips N.V.  - Income from continuing operations € (1.84) € 0.67 € 1.09
Basic earnings per common share attributable to shareholders of Koninklijke Philips N.V.  - Net income [2] (1.82) 3.67 1.31
Diluted earnings per common share attributable to shareholders of Koninklijke Philips N.V.  - Income from continuing operations (1.84) 0.67 1.08
Diluted earnings per common share attributable to shareholders of Koninklijke Philips N.V.  - Net income [2],[3] € (1.82) € 3.65 € 1.29
[1] Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[2] Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[3] The dilutive potential common shares are not taken into account in the periods for which there is a loss, as the effect would be antidilutive